Bank of Stockton’s Edwards Lifesciences EW Stock Holding History

Bank of Stockton’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,560	Closed	-$202K	–	127
2021 Q4	$202K	Buy	+1,560	New	+$182K	0.06%	124
2020 Q4	–	Sell	-3,685	Closed	-$294K	–	114
2020 Q3	$294K	Hold	3,685	–	–	0.12%	104
2020 Q2	$254K	Buy	+3,685	New	+$262K	0.11%	107
2020 Q1	–	Sell	-2,910	Closed	-$226K	–	101
2019 Q4	$226K	Hold	2,910	–	–	0.1%	102
2019 Q3	$213K	Buy	+2,910	New	+$204K	0.09%	106
2019 Q2	–	Sell	-3,210	Closed	-$204K	–	107
2019 Q1	$204K	Buy	+3,210	New	+$183K	0.1%	103

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of Stockton's EW Position: Q1 2022 in Review

Bank of Stockton sold out of Edwards Lifesciences (EW) in Q1 2022, closing a stake of 1,560 shares — an estimated $202K sold.

Bank of Stockton first reported a position in EW in Q1 2019 and held it in 6 quarters. The position peaked at $294K in Q3 2020. 1,315 funds tracked by Wall St. Rank hold EW as of Q1 2022.

Bank of Stockton reported no remaining Edwards Lifesciences position as of Q1 2022 after selling out during the quarter.
Bank of Stockton sold 1,560 Edwards Lifesciences shares in Q1 2022, an estimated $202K.
Bank of Stockton first reported a position in Edwards Lifesciences in Q1 2019 and held it in 6 quarters.
Bank of Stockton's Edwards Lifesciences position peaked at $294K in Q3 2020.
1,315 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2022.

Based on Bank of Stockton's 13F filing for Q1 2022, filed 27 Apr 2022.